[Federal Register Volume 59, Number 91 (Thursday, May 12, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-11518]


[[Page Unknown]]

[Federal Register: May 12, 1994]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES
 

National Institute on Drug Abuse; Meetings

    Pursuant to Public Law 92-463, notice is hereby given of the 
meetings of the review committees of the National Institute on Drug 
Abuse for June 1994.
    These meetings will be open to the public for approximately one-
half hour at the beginning of the first day of the meeting for 
announcements and reports of administrative, legislative, and program 
development. Attendance by the public will be limited to space 
available.
    As indicated below in accordance with provisions set forth in 
sections 552b(c)(4) and 552b(c)(6), title 5, U.S.C. and section 10(d) 
of Public Law 92-463, these meetings will be closed to the public for 
the review, discussion, and evaluation of individual grant applications 
on the dates indicated below. These applications and the discussions 
could reveal confidential trade secrets or commercial property such as 
patentable material and personal information concerning individuals 
associated with the applications, disclosure of which would constitute 
a clearly unwarranted invasion of personal privacy.
    Summaries of the meetings and rosters of committee members may be 
obtained from: Ms. Camilla L. Holland, NIDA Committee Management 
Officer, National Institutes of Health, Parklawn Building, room 10-42, 
5600 Fishers Lane, Rockville, MD 20857 (Telephone: 301/443-2755).
    Substantive program information may be obtained from the contacts 
whose names, room numbers, and telephone numbers are listed below.

    Committee Name: Pharmacology I Research Subcommittee, Drug Abuse 
Biomedical Research Review Committee.
    Meeting Date: June 13-15, 1994.
    Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 
22209.
    Open: June 13, 8:30 a.m. to 9 a.m.
    Closed: 9 a.m., June 13, to adjournment on June 15.
    Contact: Syed Husain, Ph.D., room 10-42, Parklawn Building, 
telephone (301) 443-2620.

    Committee Name: Pharmacology II Research Subcommittee, Drug 
Abuse Biomedical Research Review Committee.
    Meeting Date: June 13-15, 1994.
    Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 
22209.
    Open: June 13, 9 a.m. to 9:30 a.m.
    Closed: 9:30 a.m., June 13, to adjournment on June 15.
    Contact: Gamil Debbas, Ph.D., room 10-42, Parklawn Building, 
telephone (301) 443-2620.

    Committee Name: Biochemistry Research Subcommittee, Drug Abuse 
Biomedical Research Review Committee.
    Meeting Date: June 13-16, 1994.
    Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 
22209.
    Open: June 13, 8:30 a.m. to 9 a.m.
    Closed: 9 a.m., June 13, to adjournment on June 16.
    Contact: Rita Liu, Ph.D., room 10-42, Parklawn Building, 
telephone (301) 443-2620.

    Committee Name: Drug Abuse Epidemiology and Prevention Research 
Review Committee.
    Meeting Date: June 14-17, 1994.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 
Bethesda, MD 20814.
    Open: June 14, 8:30 a.m. to 9 a.m.
    Closed: 9 a.m., June 14, to adjournment on June 17.
    Contact: Raquel Crider, Ph.D., room 10-22, Parklawn Building, 
telephone (301) 443-9042.

    Individuals who plan to attend and need special assistance, such 
as sign language interpretation or other reasonable accommodations, 
should contact the contact persons named above in advance of the 
meeting.

(Catalog of Federal Domestic Assistance Program Numbers: 93.277, 
Drug Abuse Research Scientist Development and Research Scientist 
Awards; 93.278, Drug Abuse National Research Service Awards for 
Research Training; 93.279, Drug Abuse Research Programs.)

    Dated: May 5, 1994.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 94-11518 Filed 5-11-94; 8:45 am]
BILLING CODE 4140-01-M